A Prospective Randomized Study to Assess the Efficacy of Rate and Site of Atrial Pacing on Long-Term Development of Atrial Fibrillation
CHU-PAK LAU M.D.
Queen Mary Hospital, University of Hong Kong, Hong Kong
Search for more papers by this authorCHUN-CHIEH WANG M.D.
Chang Gung Memorial Hospital, Linkou, Taiwan
Search for more papers by this authorTACHAPONG NGARMUKOS M.D.
Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
Search for more papers by this authorCHARN SRIRATANASATHAVORN M.D.
Siriraj Hospital, Mahidol University, Bangkok, Thailand
Search for more papers by this authorKATHY LF LEE M.D.
Queen Mary Hospital, University of Hong Kong, Hong Kong
Search for more papers by this authorHUNG-FAT TSE M.D., Ph.D.
Queen Mary Hospital, University of Hong Kong, Hong Kong
Search for more papers by this authorSAFE Study Steering Committee for the SAFE Study Group
The complete SAFE Study Group is listed in the Appendix 1.
Search for more papers by this authorCHU-PAK LAU M.D.
Queen Mary Hospital, University of Hong Kong, Hong Kong
Search for more papers by this authorCHUN-CHIEH WANG M.D.
Chang Gung Memorial Hospital, Linkou, Taiwan
Search for more papers by this authorTACHAPONG NGARMUKOS M.D.
Ramathibodi Hospital, Mahidol University, Bangkok, Thailand
Search for more papers by this authorCHARN SRIRATANASATHAVORN M.D.
Siriraj Hospital, Mahidol University, Bangkok, Thailand
Search for more papers by this authorKATHY LF LEE M.D.
Queen Mary Hospital, University of Hong Kong, Hong Kong
Search for more papers by this authorHUNG-FAT TSE M.D., Ph.D.
Queen Mary Hospital, University of Hong Kong, Hong Kong
Search for more papers by this authorSAFE Study Steering Committee for the SAFE Study Group
The complete SAFE Study Group is listed in the Appendix 1.
Search for more papers by this authorThis study is supported by St. Jude Medical Inc.
Dr. Lau received funds to support the core lab; he also received travel support to an investigators’ meeting and holding shares of common stock in an unspecified company relevant to this topic. Dr. Wang served as a member of the steering committee of the SAFE study. Dr. Ngarmukos received financial support for travel to an investigators’ meeting. Drs. Kong and Omar served on the advisory board of the SAFE study. Dr. Kam received travel support from Medtronic International to present poster at a meeting and also served on the clinical advisory boards of St. Jude Medical and Medtronic International Inc.
Abstract
The Septal Pacing for Atrial Fibrillation Suppression Evaluation (SAFE) study is a single-blinded, parallel randomized designed multicenter study in pacemaker indicated patients with paroxysmal atrial fibrillation (AF). The objective is to evaluate whether the site of atrial pacing–-conventional right atrial appendage versus low atrial septal—with or without atrial overdrive pacing will influence the development of persistent AF. The study will provide a definitive answer to whether a different atrial pacing site or the use of AF suppression pacing or both can give incremental antiarrhythmic benefit when one is implanting a device for a patient with a history of paroxysmal AF.
References
- 1 Lamas GA, Lee KL, Sweeney MO, Silverman R, Leon A, Yee R, Marinchak RA, Flaker G, Schron E, Orav J, Hellkamp AS, Goldman L, for the mode selection trial in sinus-node dysfunction: Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 2002; 346: 1854-1862.
- 2 Tse HF, Lau CP: Prevalence and clinical implications of atrial fibrillation episodes detected by pacemaker in patients with sick sinus syndrome. Heart 2005; 91: 362-364.
- 3 Healey JS, Toff WD, Lamas GA, Anderson HR, Thorpe KE, Ellenbogen KA, Lee KL, Skene AM, Schron EB, Skehan JD, Goldman L, Roberts RS, Camm AJ, Yusuf S, Connolly SJ: Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing: Meta analysis of randomized trials, using individual patient data. Circulation 2006; 114: 11-17.
- 4 Glotzer TV, Hellkamp AS, Zimmerman J, Sweeney MO, Yee R, Marinchak R, Cook J, Paraschos A, Love J, Radoslovich G, Lee KL, Lamas GA, for the MOST Investigators: Atrial high rate episodes detected by pacemaker diagnostics predict death and stroke: Report of the atrial diagnostics ancillary study of the mode selection trial (MOST). Circulation 2003; 107: 1614-1619.
- 5 Sweeney MO, Bank AJ, Nsah E, Koullick M, Zeng QC, Hettrick D, Sheldon T, Lamas GA, for the search AV extension and managed ventricular pacing for promoting atrioventricular conduction (SAVE PACe) trial: Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease. N Engl J Med 2007; 357: 1000-1008.
- 6 Olshansky B, Day JD, Moore S, Gering L, Rosenbaum M, Mcguire M, Brown S, Lerew DR: Is dual-chamber programming inferior to single-chamber programming in an implantable cardioverter-defibrillator? Results of the INTRINSIC RV (inhibition of unnecessary RV pacing with AVSH in ICDs) study. Circulation 2007; 115: 9-16.
- 7 Carlson MD, Ip J, Messenger J, Beau S, Kalbfleisch S, Gervais P, Cameron DA, Duran A, Val-Mejias J, Mackall J, Gold M, for ADOPT Investigators: A new pacemaker algorithm for the treatment of atrial fibrillation: Results of the atrial dynamic overdrive pacing trial (ADOPT). J Am Coll Cardiol 2003; 42: 627-633.
- 8 Padeletti L, Pürerfellner H, Adler SW, Waller TJ, Harvey M, Horvitz L, Holbrook R, Kempen K, Mugglin A, Hettrick D, for the Worldwide ASPECT Investigators: Combined efficacy of atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial tachyarrhythmia. J Cardiovasc Electrophysiol 2003; 14: 1189-1195.
- 9 Lee MA, Weachter R, Pollak S, Kremers MS, Naik AM, Silverman R, Tuzi J, Wang W, Johnson LJ, Euler DE, for the ATTEST Investigators: The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency. J Am Coll Cardiol 2003; 41: 1926-1932.
- 10 Israel CW, Hohnloser SH: Pacing to prevent atrial fibrillation. J Cardiovasc Electrophysiol 2003; 14: S20-S26.
- 11 Knight BP, Gersh BJ, Carlson MD, Friedman PA, McNamara RL, Strickberger SA, Tse HF, Waldo AL, American Heart Association Council on Clinical Cardiology (Subcommittee on Electrocardiography and Arrhythmias); Quality of Care and Outcomes Research Interdisciplinary Working Group; Heart Rhythm Society; AHA Writing Group: Role of permanent pacing to prevent atrial fibrillation: Science advisory from the American Heart Association Council on Clinical Cardiology (subcommittee on Electrocardiography and Arrhythmias) and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society. Circulation 2005; 111: 240-243.
- 12 Savelieva I, Camm AJ: The results of pacing trials for the prevention and termination of atrial tachyarrhythmias: Is there any evidence of therapeutic breakthrough? J Interv Card Electrophysiol 2003; 8: 103-115.
- 13 Lam CTF, Lau CP, Leung SK, Tse HF, Lee KLF, Tang MO, Tsang V: Efficacy and tolerability of continuous overdrive atrial pacing in atrial fibrillation. Europace 2000; 2: 286-291.
- 14 Gold MR, Hoffmann E: The impact of atrial prevention pacing on AF burden: Primary results of the study for atrial fibrillation reduction (SAFARI) trial. Europace 2006; 8(S1): 222-223.
- 15 Kerr CR, Connolly SJ, Abdollah H, Roberts RS, Gent M, Yusuf S, Gillis AM, Tang ASL, Talajic M, Klein GJ, Newman DM, for the Canadian Trial of Physiological Pacing (CTOPP) Investigators: Canadian trial of physiological pacing: Effects of physiological pacing during long-term follow-up. Circulation 2004; 109: 357-362.
- 16 Bailin SJ, Adler S, Giudici M: Prevention of chronic atrial fibrillation by pacing in the region of Bachmann's bundle: Results of a multicenter randomized trial. J Cardiovasc Electrophysiol 2001; 12: 912-917.
- 17 Padeletti L, Porciani MC, Michelucci A, Colella A, Ticci P, Vena S, Costoli A, Ciapetti C, Pieragnoli P, Gensini GF: Interatrial septum pacing: A new approach to prevent recurrent atrial fibrillation. J Interv Card Electrophysiol 1999; 3: 35-43.
- 18 Padeletti L, Pieragnoli P, Ciapetti C, Colella A, Musilli N, Porciani MC, Ricci R, Pignalberi C, Santini M, Puglisi A, Azzolini P, Spampinato A, Martelli M, Capucci A, Boriani G, Botto G, Proclemer A: Randomized crossover comparison of right atrial appendage pacing versus interatrial septum pacing for prevention of paroxysmal atrial fibrillation in patients with sinus bradycardia. Am Heart J 2001; 142: 1047-1055.
- 19 De Voogt W, Van Hemel N, De Vusser P, Mairesse GH, Van Mechelen R, Koistinen J, Van Den Bos A, Roose I, Voitk J, Yli-Mäyry S, Stockman D, El Allaf D, Tse HF, Lau CP: No evidence of automatic atrial overdrive pacing efficacy on reduction of paroxysmal atrial fibrillation. Europace 2007; 9: 798-804.
- 20 Spitzer SG, Gazarek S, Wacker P, Malinowski K, Schibgilla V: Pacing of the atria in sick sinus syndrome trial: Preventive strategies for atrial fibrillation. Pacing Clin Electrophysiol 2003; 26(Pt II): 268-271.
- 21 Epstein AE, DiMarco JP, Ellenbogen KA, Estes NAM, III, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO: ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Writing Committee to revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices): Developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008; 117: e350-e408.
- 22 Hohnloser SH, Capucci A, Fain E, Gold MR, Van Gelder IC, Healey J, Israel CW, Lau CP, Morillo C, Connolly SJ. On behalf of the ASSERT Investigators and Committees: Asymptomatic atrial fibrillation and stroke evaluation in pacemaker patients and the atrial fibrillation reduction atrial pacing trial (ASSERT). Am Heart J 2006; 152: 442-447.
- 23 Kolb C, Aratma S, Zrenner B, Schmitt C: Preventricular far-field sensing in the atrial channel of dual chamber pacemakers: An occasional cause of inappropriate mode switch. J Interv Card Electrophysiol 2004; 10: 231-235.
- 24 Ware JE, Sherbourne CD: The MOS 36-item short-form health status survey (SF-36): Conceptual framework and item selection. Med Care 1992; 30: 473-483.
- 25 Agresti A: Categorical Data Analysis. Wiley InterScience; 1990, pp. 79-116, 165-198.
- 26 Lau CP, Tse HF, Yu CM, Teo WS, Kam R, Ng KS, Huang SSK, Lin JL, Fitts SM, Hettrick DA, Hill MRS, for the New Indications for Preventive Pacing in Atrial Fibrillation (NIPP-AF) Investigators: Dual-site atrial pacing for atrial fibrillation in patients without bradycardia. Am J Cardiol 2001; 88: 371-375.
- 27 Saksena S, Prakash A, Ziegler P, Hummel JD, Friedman P, Plumb VJ, Wyse G, Johnson E, Fitts S, Mehra R, for DAPPAF Investigators: Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and Antiarrhythmic drug therapy. J Am Coll Cardiol 2002; 40: 1140-1150.
- 28 Mirza I, James S, Holt P: Biatrial pacing for paroxysmal atrial fibrillation. A randomized prospective study into the suppression of paroxysmal atrial fibrillation using biatrial pacing. J Am Coll Cardiol 2002; 40: 457-463.
- 29 Bacik BM, Muller D, Corbisiero R: Adaptive bi-atrial pacing improves the maintenance of sinus rhythm. Pacing Clin Electrophysiol 2007; 30: 492-497.